Vitalhub (TSE:VHI - Get Free Report) had its price target boosted by Scotiabank from C$14.00 to C$14.50 in a research note issued to investors on Friday,BayStreet.CA reports. The brokerage presently has an "outperform" rating on the stock. Scotiabank's price objective would suggest a potential upside of 31.34% from the stock's previous close.
Several other research firms have also weighed in on VHI. National Bankshares set a C$14.00 target price on Vitalhub and gave the stock an "outperform" rating in a report on Tuesday, June 10th. TD Securities boosted their price objective on shares of Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research note on Monday, March 31st. National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Finally, Raymond James Financial set a C$13.50 target price on shares of Vitalhub and gave the company an "outperform" rating in a research note on Thursday, March 27th. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of C$13.25.
View Our Latest Stock Analysis on VHI
Vitalhub Stock Performance
Shares of VHI traded down C$0.11 during trading hours on Friday, hitting C$11.04. 83,726 shares of the company were exchanged, compared to its average volume of 127,233. The company has a market cap of C$597.18 million, a PE ratio of 179.56, a PEG ratio of 1.18 and a beta of 1.26. The firm's 50 day moving average is C$10.60 and its 200-day moving average is C$10.61. Vitalhub has a 52 week low of C$6.74 and a 52 week high of C$12.34.
Insider Transactions at Vitalhub
In other news, Director Francis Nelson Shen bought 25,000 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is currently owned by corporate insiders.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading

Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.